Catalyst Wire Dossier Catalyst Wire Dossier

SAPHNELO

ANIFROLUMAB-FNIA · AstraZeneca Pharmaceuticals LP
Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for SAPHNELO, covering 2021-07-30 to 2026-08-07. Get the full timeline:

Most recent: FDA Approved: SAPHNELO — Supplemental Application (AstraZeneca Pharmaceuticals LP)

See pricing